PHYEX | PRHCX | PHYEX / PRHCX | |
Total Expense Ratio | 0.91 | 1.47 | 62% |
Annual Report Gross Expense Ratio | 0.94 | 1.47 | 64% |
Fund Existence | 8 years | 31 years | - |
Gain YTD | 5.833 | 5.483 | 106% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 1000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 20.5B | 20.5B | 100% |
Annual Yield % from dividends | 6.81 | 6.25 | 109% |
Returns for 1 year | 9.37 | 8.76 | 107% |
Returns for 3 years | 22.22 | 20.17 | 110% |
Returns for 5 years | 24.32 | 20.83 | 117% |
Returns for 10 years | N/A | 56.27 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
OCTT | 41.35 | 0.33 | +0.81% |
AllianzIM US Large Cap Buffer10 Oct ETF | |||
ETW | 8.94 | 0.02 | +0.22% |
Eaton Vance Tax-Managed Global Buy-Write Opportunities Fund | |||
BNY | 9.66 | 0.02 | +0.21% |
BlackRock New York Municipal Income Trust | |||
XDAT | 26.20 | N/A | N/A |
Franklin Exponential Data ETF | |||
THNR | 22.00 | N/A | N/A |
Amplify Weight Loss Drug & Treatment ETF |